We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HOOD:NASDAQRobinhood Markets, Inc. Analysis

Data as of 2026-07-18 - not real-time

$99.96

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Robinhood (HOOD) is trading at $99.96, well below its 20‑day SMA of $107.29, indicating short‑term weakness. The 50‑day SMA sits at $93.02, so the stock remains above that longer‑term support, creating a mixed moving‑average picture. Technical momentum is bearish, with the MACD histogram at –1.50 and a “bearish” signal line crossover. RSI at 46.6 suggests the stock is neither oversold nor overbought, reinforcing a neutral stance. Volume has been decreasing, hinting at waning buying pressure despite a recent 17% monthly gain. The market’s “Extreme Greed” sentiment (fear‑greed index 87.9) may be inflating price expectations.
Fundamentally, HOOD posts 15% revenue growth, a 92% gross margin and a 38% operating margin, underscoring a high‑margin business model. However, the forward PE of 32.5 versus an industry average of 17.8, and a DCF fair value of $63.73, signal that the stock is significantly overvalued. The company carries a heavy debt load (debt‑to‑equity >140) and a beta above 3, exposing it to market swings and financial risk. Upcoming Q2 earnings on July 29 could clarify whether growth can sustain the lofty valuation. Recent positive news—such as a Goldman Sachs target raise and a new blockchain launch—has helped the stock rally to $115 in recent sessions. Investors should weigh the strong margins and cash position against the regulatory headwinds and valuation gap before committing capital.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price below 20‑day SMA
  • bearish MACD crossover
  • declining volume trend

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • 15% revenue growth
  • high gross and operating margins
  • analyst consensus buy and target price above current

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • elevated debt‑to‑equity ratio
  • high beta and market volatility
  • regulatory uncertainty in fintech sector

Key Metrics & Analysis

Financial Health

Revenue Growth15.10%
Profit Margin41.12%
P/E Ratio51.5
ROE21.46%
ROA5.19%
Debt/Equity140.48
P/B Ratio9.7
Op. Cash Flow$3.0B
Industry P/E17.8

Technical Analysis

TrendNeutral
RSI46.6
Support$92.80
Resistance$120.05
MA 20$107.29
MA 50$93.02
MA 200$101.75
MACDBearish
VolumeDecreasing
Fear & Greed Index87.91

Valuation

Fair Value$63.73
Target Price$118.28
Upside/Downside18.33%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta3.05
Volatility72.23%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.